Prediction of Sustained Virological Response to Peginterferon-based Therapy for Chronic Hepatitis C: Regression Analysis of a Cohort from Rio Grande do Sul, Brazil

Por V Picon, Rafael, Fendt, Lúcia, Amaral, Karine, D Picon, Paulo
Publicado no Euroasian J Hepatogastroenterol (2017)

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

Por Artico, Simara, Amaral, Karine Medeiros, Gonçalves, Candice Beatriz Treter, Picon, Paulo Dornelles
Publicado em 2012

Randomized clinical trial of a phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation

Por Picon, Paulo D, Picon, Rafael V, Costa, Andry F, Sander, Guilherme B, Amaral, Karine M, Aboy, Ana L, Henriques, Amélia T
Publicado em 2010

Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene

Por Grandi, Tarciana, da Silva, Cláudia Maria Dornelles, Amaral, Karine Medeiros, Picon, Paulo Dornelles, Costi, Cintia, da Fré, Nicole Nascimento, Fiegenbaum, Marilu, Niel, Christian, Rossetti, Maria Lucia Rosa
Publicado em 2013

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients

Por Grandi, Tarciana, da Silva, Cláudia Maria Dornelles, Amaral, Karine Medeiros, Picon, Paulo Dornelles, Costi, Cintia, da Fré, Nicole Nascimento, Fiegenbaum, Marilu, Gregianini, Tatiana Schäffer, Niel, Christian, Rossetti, Maria Lucia Rosa
Publicado em 2014